| Customization: | Available |
|---|---|
| Certification: | ISO, FDA, Halal, Kosher |
| Assay Method: | HPLC |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
IDRA-21 is a relatively new nootropic compound. It works as an ampakine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits.
|
Product Name
|
IDRA 21 |
|
Latin Name
|
IDRA 21;IDRA 21,7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazineS,S-dioxide; |
|
CAS No
|
22503-72-6 |
|
Specification
|
98% |
|
Appearance
|
White powder
|
|
Grade
|
food,cosmetic
|
|
Test Method
|
HPLC
|
|
Shelf Life
|
2 Years
|
1. Increases in cognitive ability.
2. Increased accuracy when completing tasks.
3. Increases in short term memory.
4. IDRA-21 can potentially treat schizophrenia.
5. IDRA-21 can possibly be a treatment for depression.
6. IDRA-21 has a neuroprotective effect, so it can protect the brain from age-related cognitive defects.
7. Increased alertness and wakefulness
| Product name | CAS | Product name | CAS |
| Tianeptine | 30123-17-2 | Noopept | 157115-85-0 |
| Alpha GPC | 28319-77-9 | Sunifiram | 314728-85-3 |
| Coluracetam | 135463-81-9 | Aniracetam | 72432-10-1 |
| PRL-8-53 | 51352-87-5 | Oxiracetam | "68252-28-8 62613-82-5" |
| phenibute | 1078-21-3 | IDRA 21 | 22503-72-6 |
| Fasoracetam | 110958-19-5 | NSI189 | 1270138-40-3 |
| Sulbutamine | 3286-46-2 | NSI189 Phosphate | 1270138-41-4 |
| CDP Choline/Citicoline | 33818-15-4 | Vinpocetine | 42971-09-5 |
){kind=link}